Clinical Trials Logo

Clinical Trial Summary

The clinical decision-making after kidney transplantation is mainly driven by patient individual assessment. However, this task remains difficult and uncertain due to the integration of complex and numerous parameters. We aim to evaluate and compare the ability of transplant physicians to predict long term allograft survival compared with a computer-based survival prediction algorithm (iBox system).


Clinical Trial Description

400 kidney transplant recipients among the cohort of 4,000 patients from the Paris Transplant Group prospective kidney transplant cohort (NCT03474003) were randomly selected. We generated an anonymized electronic health record for each included patient including a total of 60 classical kidney transplant prognostic parameters comprising baseline transplant and recipient characteristics, together with post-transplant parameters including allograft function, proteinuria, histology, diagnoses, and immunological profile collected during the first-year post-transplant. The time of risk evaluation for the human and the iBox system were at 1-year post transplant and the death censored allograft survival predictions made at 7 years after risk assessment. We enrolled transplant physicians at various stages of their careers (residents, fellows and seniors) to assign death censored graft survival probabilities at 7 years post risk assessment. The physicians were blinded to the actual patient outcome (allograft failure) and the iBox predictions. The physicians-based predictions will then be compared with the iBox system, a validated computer-based kidney survival prediction system. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04918199
Study type Observational
Source Paris Translational Research Center for Organ Transplantation
Contact
Status Completed
Phase
Start date March 1, 2018
Completion date December 31, 2021

See also
  Status Clinical Trial Phase
Withdrawn NCT04560582 - Immunosuppression Reduction in Failed Allograft Guided by cfDNA
Withdrawn NCT04216303 - Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus
Recruiting NCT03689075 - Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisation Phase 4
Recruiting NCT05788276 - Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys? Phase 4
Recruiting NCT03870542 - Multicenter, Prospective Study for Urinary Exosomal Biomarkers of Kidney Allograft Tubulointerstitial Fibrosis
Active, not recruiting NCT04882254 - Normothermic Machine Perfusion: an Additional Value for Kidney Transplant Outcomes? Phase 2
Active, not recruiting NCT04897438 - Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection N/A
Enrolling by invitation NCT05285878 - Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation Phase 2
Recruiting NCT04226859 - Trajectories of Glomerular Filtration Rate and Progression to End Stage Renal Disease After Kidney Transplantation
Recruiting NCT06056518 - Investigating the Impact of AI on Shared Decision Making in Post-kidney Transplant Care N/A
Completed NCT05619679 - A Clinical Practice Snapshot on Pediatric Kidney Transplantation
Completed NCT06020534 - Aortoiliac Stenosis in Kidney Transplantation
Active, not recruiting NCT02960802 - Kidney Transplantation and Renal and Myocardial Perfusion N/A
Completed NCT05200949 - SURGICAL EXPERIENCE ON RENAL TRANSPLANT COMPLICATIONS
Completed NCT04258891 - Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation
Recruiting NCT06186843 - Plant-based Diet for Kidney Transplant Recipients N/A
Active, not recruiting NCT04154267 - Protocol Biopsies in High-risk Renal Transplant Recipients N/A